Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Evangelos Terpos

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Antineoplastic Combined Chemotherapy Protocols

Physiology

Anatomy

Osteoclasts

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Roussou M; Tasidou A; Dimopoulos M A; Kastritis E; Migkou M; Christoulas D; Gavriatopoulou M; Zagouri F; Matsouka C; Anagnostou D; Terpos E
Increased expression of macrophage inflammatory protein-1alpha on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma.
Polyzos Stergios A; Anastasilakis Athanasios D; Terpos Evangelos
Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid.
Anastasilakis A D; Toulis K A; Goulis D G; Polyzos S A; Delaroudis S; Giomisi A; Terpos E
Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Evangelos Terpos (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Roussou M; Tasidou A; Dimopoulos M A; Kastritis E; Migkou M; Christoulas D; Gavriatopoulou M; Zagouri F; Matsouka C; Anagnostou D; Terpos E
Increased expression of macrophage inflammatory protein-1alpha on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(11):2177-81.
2009: Polyzos Stergios A; Anastasilakis Athanasios D; Terpos Evangelos
Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009;17(10):1329-30.
2009: Anastasilakis A D; Toulis K A; Goulis D G; Polyzos S A; Delaroudis S; Giomisi A; Terpos E
Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysis.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2009;41(10):721-9.
2009: Dimopoulos Meletios-Athanassios; Moulopoulos Lia A; Terpos Evangelos
A new pet for myeloma.
Blood 2009;114(10):2007-8.
2009: Dimopoulos Meletios A; Roussou Maria; Gavriatopoulou Maria; Zagouri Flora; Migkou Magdalini; Matsouka Charis; Barbarousi Despina; Christoulas Dimitrios; Primenou Erasmia; Grapsa Irini; Terpos Evangelos; Kastritis Efstathios
Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors.
Clinical lymphoma & myeloma 2009;9(4):302-6.
2009: Anastasilakis Athanasios D; Toulis Konstantinos A; Polyzos Stergios A; Terpos Evangelos
RANKL inhibition for the management of patients with benign metabolic bone disorders.
Expert opinion on investigational drugs 2009;18(8):1085-102.
2009: Katodritou Eirini; Ganz Tomas; Terpos Evangelos; Verrou Evgenia; Olbina Gordana; Gastari Vassiliki; Hadjiaggelidou Christina; Varthaliti Maria; Georgiadou Sofia; Westerman Mark; Zervas Konstantinos
Sequential evaluation of serum hepcidin in anemic myeloma patients: study of correlations with myeloma treatment, disease variables, and anemia response.
American journal of hematology 2009;84(8):524-6.
2009: Terpos E; Sezer O; Croucher P I; García-Sanz R; Boccadoro M; San Miguel J; Ashcroft J; Bladé J; Cavo M; Delforge M; Dimopoulos M-A; Facon T; Macro M; Waage A; Sonneveld P;
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(8):1303-17.
2009: Gavriatopoulou Maria; Dimopoulos Meletios-Athanasios; Christoulas Dimitrios; Migkou Magdalini; Iakovaki Marina; Gkotzamanidou Maria; Terpos Evangelos
Dickkopf-1: a suitable target for the management of myeloma bone disease.
Expert opinion on therapeutic targets 2009;13(7):839-48.
2009: Kastritis E; Zervas K; Symeonidis A; Terpos E; Delimbassi S; Anagnostopoulos N; Michali E; Zomas A; Katodritou E; Gika D; Pouli A; Christoulas D; Roussou M; Kartasis Z; Economopoulos T; Dimopoulos M A
Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(6):1152-7.
2009: Terpos Evangelos; Kiagia Maria; Karapanagiotou Eleni M; Charpidou Adrianni; Dilana Kaliopi D; Nasothimiou Efthimia; Harrington Kevin J; Polyzos A; Syrigos Kostas N
The clinical significance of serum markers of bone turnover in NSCLC patients: surveillance, management and prognostic implications.
Anticancer research 2009;29(5):1651-7.
2009: Voskaridou Ersi; Christoulas Dimitrios; Xirakia Charoula; Varvagiannis Konstantinos; Boutsikas Georgios; Bilalis Antonios; Kastritis Efstathios; Papatheodorou Athanasios; Terpos Evangelos
Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration.
Haematologica 2009;94(5):725-8.
2009: Terpos Evangelos; Cibeira M Teresa; Blade Joan; Ludwig Heinz
Management of complications in multiple myeloma.
Seminars in hematology 2009;46(2):176-89.
2009: Terpos Evangelos; Efstathiou Eleni; Christoulas Dimitrios; Roussou Maria; Katodritou Eirini; Dimopoulos Meletios-Athanassios
RANKL inhibition: Clinical implications for the management of patients with multiple myeloma and solid tumors with bone metastases.
Expert opinion on biological therapy 2009;9(4):465-79.
2009: Dimopoulos Meletios A; Kastritis Efstathios; Roussou Maria; Eleutherakis-Papaiakovou Evangelos; Migkou Magdalini; Gavriatopoulou Maria; Tassidou Anna; Terpos Evangelos
Rituximab-based treatments in Waldenström's macroglobulinemia.
Clinical lymphoma & myeloma 2009;9(1):59-61.
2009: Kastritis Efstathios; Zervas Konstantinos; Repoussis Panagiotis; Michali Evridiki; Katodrytou Eirini; Zomas Athanasios; Simeonidis Argiris; Terpos Evangelos; Delimbassi Sossana; Vassou Amalia; Gika Dimitra; Dimopoulos Meletios A;
Prognostication in young and old patients with Waldenström's macroglobulinemia: importance of the International Prognostic Scoring System and of serum lactate dehydrogenase.
Clinical lymphoma & myeloma 2009;9(1):50-2.
2009: Terpos Evangelos; Tasidou Anna; Kastritis Efstathios; Eleftherakis-Papaiakovou Evangelos; Gavriatopoulou Maria; Migkou Magdalini; Dimopoulos Meletios-Athanassios
Angiogenesis in Waldenström's macroglobulinemia.
Clinical lymphoma & myeloma 2009;9(1):46-9.
2009: Terpos Evangelos; Katodritou Eirini; Tsiftsakis Evangelos; Kastritis Efstathios; Christoulas Dimitrios; Pouli Anastasia; Michalis Eurydiki; Verrou Evgenia; Anargyrou Konstantinos; Tsionos Konstantinos; Dimopoulos Meletios A; Zervas Konstantinos;
Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration.
Haematologica 2009;94(3):372-9.
2009: Spanoudakis Emmanouil; Hu Ming; Naresh Kikkeri; Terpos Evangelos; Melo Valeria; Reid Alistair; Kotsianidis Ioannis; Abdalla Saad; Rahemtulla Amin; Karadimitris Anastasios
Regulation of multiple myeloma survival and progression by CD1d.
Blood 2009;113(11):2498-507.
2009: Migkou Magda; Dimopoulos Meletios-Athanassios; Gavriatopoulou Maria; Terpos Evangelos
Applications of monoclonal antibodies for the treatment of hematological malignancies.
Expert opinion on biological therapy 2009;9(2):207-20.
2009: Major Pierre P; Cook Richard J; Lipton Allan; Smith Matthew R; Terpos Evangelos; Coleman Robert E
Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity.
BMC cancer 2009;9():272.
2008: Kastritis Efstathios; Katoulis Alexandros; Terpos Evangelos; Panayiotides Ioannis; Gavriatopoulopu Maria; Dimopopoulos Meletios A
Schnitzler's syndrome: increased levels of bone formation and angiogenesis factors are reduced after successful pefloxacin treatment.
Clinical lymphoma & myeloma 2008;8(6):359-62.
2008: Terpos Evangelos
Bortezomib directly inhibits osteoclast function in multiple myeloma: implications into the management of myeloma bone disease.
Leukemia research 2008;32(11):1646-7.
2008: Coleman Robert; Brown Janet; Terpos Evangelos; Lipton Allan; Smith Matthew R; Cook Richard; Major Pierre
Bone markers and their prognostic value in metastatic bone disease: clinical evidence and future directions.
Cancer treatment reviews 2008;34(7):629-39.
2008: Terpos Evangelos; Voskaridou Ersi
Interactions between osteoclasts, osteoblasts and immune cells: implications for the pathogenesis of bone loss in thalassemia.
Pediatric endocrinology reviews : PER 2008;6 Suppl 1():94-106.
2008: Voskaridou Ersi; Terpos Evangelos
Pathogenesis and management of osteoporosis in thalassemia.
Pediatric endocrinology reviews : PER 2008;6 Suppl 1():86-93.
2008: Terpos Evangelos; Dimopoulos Meletios-Athanassios
Genetic predisposition for the development of ONJ.
Blood 2008;112(7):2596-7.
2008: Voskaridou Ersi; Christoulas Dimitrios; Konstantinidou Marialena; Tsiftsakis Evangelos; Alexakos Panagiotis; Terpos Evangelos
Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial.
Haematologica 2008;93(10):1588-90.
2008: Katodritou Eirini; Verrou Evgenia; Hadjiaggelidou Christina; Gastari Vassiliki; Laschos Konstantinos; Kontovinis Loukas; Kapetanos Dimitrios; Constantinou Nikos; Terpos Evangelos; Zervas Konstantinos
Erythropoiesis-stimulating agents are associated with reduced survival in patients with multiple myeloma.
American journal of hematology 2008;83(9):697-701.
2008: Badros Ashraf; Goloubeva Olga; Terpos Evangelos; Milliron Todd; Baer Maria R; Streeten Elizabeth
Prevalence and significance of vitamin D deficiency in multiple myeloma patients.
British journal of haematology 2008;142(3):492-4.
2008: Lipton Allan; Cook Richard; Saad Fred; Major Pierre; Garnero Patrick; Terpos Evangelos; Brown Janet E; Coleman Robert E
Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid.
Cancer 2008;113(1):193-201.
2008: Katodritou Eirini; Zervas Konstantinos; Terpos Evangelos; Brugnara Carlo
Use of erythropoiesis stimulating agents and intravenous iron for cancer and treatment-related anaemia: the need for predictors and indicators of effectiveness has not abated.
British journal of haematology 2008;142(1):3-10.
2008: Katodritou Eirini; Verrou Evgenia; Gastari Vassiliki; Hadjiaggelidou Christina; Terpos Evangelos; Zervas Konstantinos
Response of primary plasma cell leukemia to the combination of bortezomib and dexamethasone: do specific cytogenetic and immunophenotypic characteristics influence treatment outcome?
Leukemia research 2008;32(7):1153-6.
2008: Sterz Jan; von Metzler Ivana; Hahne Jens-Claus; Lamottke Britta; Rademacher Jessica; Heider Ulrike; Terpos Evangelos; Sezer Orhan
The potential of proteasome inhibitors in cancer therapy.
Expert opinion on investigational drugs 2008;17(6):879-95.
2008: Pilichou Anastasia; Papassotiriou Ioannis; Michalakakou Kelly; Fessatou Smaragdi; Fandridis Emmanuel; Papachristou George; Terpos Evangelos
High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-kappa B ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis.
Clinical biochemistry 2008;41(9):746-9.
2008: Terpos Evangelos; Roussou Maria; Dimopoulos Meletios-Athanassios
Bortezomib in multiple myeloma.
Expert opinion on drug metabolism & toxicology 2008;4(5):639-54.
2008: Roussou Maria; Kastritis Efstathios; Migkou Magdalini; Psimenou Erasmia; Grapsa Irini; Matsouka Charis; Barmparousi Despina; Terpos Evangelos; Dimopoulos Meletios Athanasios
Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens.
Leukemia & lymphoma 2008;49(5):890-5.
2008: Terpos Evangelos; Sarantopoulos Angelos; Kouramba Anna; Katsarou Olga; Stavropoulos John; Masouridi Stavroula; Karafoulidou Anastasia; Meletis John
Reduction of CD55 and/or CD59 in red blood cells of patients with HIV infection.
Medical science monitor : international medical journal of experimental and clinical research 2008;14(5):CR276-280.
2008: Anargyrou Konstantinos; Dimopoulos Meletios-Athanassios; Sezer Orhan; Terpos Evangelos
Novel anti-myeloma agents and angiogenesis.
Leukemia & lymphoma 2008;49(4):677-89.
2008: Zoi Katerina; Terpos Evangelos; Zoi Christine; Loukopoulos Dimitris
Increased CD177 (PRV1) expression in thalassaemia and the underlying erythropoietic activity.
British journal of haematology 2008;141(1):100-4.
2008: Mountzios Giannis; Terpos Evangelos; Dimopoulos Meletios-Athanassios
Aurora kinases as targets for cancer therapy.
Cancer treatment reviews 2008;34(2):175-82.
2008: Terpos Evangelos
Have myeloma cells osteoclast-like activity? Implications into the pathogenesis of myeloma bone disease.
Leukemia research 2008;32(4):521-2.
2008: Anargyrou Konstantinos; Terpos Evangelos; Vassilakopoulos Theodoros P; Pouli Anastasia; Sachanas Sotirios; Tzenou Tatiana; Masouridis Stavroula; Christoulas Dimitrios; Angelopoulou Maria K; Dimitriadou Evangelia M; Kalpadakis Christina; Tsionos Konstantinos; Panayiotidis Panayiotis; Dimopoulos Meletios A; Pangalis Gerassimos A; Kyrtsonis Marie-Christine;
Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib.
Haematologica 2008;93(3):451-4.
2008: Bamias Aristotelis; Koutsoukou Vasiliki; Terpos Evangelos; Tsiatas Marinos L; Liakos Christina; Tsitsilonis Ourania; Rodolakis Alexandros; Voulgaris Zannis; Vlahos G; Papageorgiou Theocharis; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos M A
Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
Gynecologic oncology 2008;108(2):421-7.
2008: Voskaridou Ersi; Christoulas Dimitrios; Antoniadou Lito; Terpos Evangelos
Continuous increase in erythropoietic activity despite the improvement in bone mineral density by zoledronic acid in patients with thalassemia intermedia-induced osteoporosis.
Acta haematologica 2008;119(1):40-4.
2007: Dimopoulos Meletios A; Souliotis Vassilis L; Anagnostopoulos Athanasios; Bamia Christina; Pouli Anastasia; Baltadakis Ioannis; Terpos Evangelos; Kyrtopoulos Soterios A; Sfikakis Petros P
Melphalan-induced DNA damage in vitro as a predictor for clinical outcome in multiple myeloma.
Haematologica 2007;92(11):1505-12.
2007: Kastritis Efstathios; Anagnostopoulos Athanasios; Roussou Maria; Toumanidis Savvas; Pamboukas Constantinos; Migkou Magdalini; Tassidou Anna; Xilouri Irini; Delibasi Sossana; Psimenou Erasmia; Mellou Sofia; Terpos Evangelos; Nanas John; Dimopoulos Meletios A
Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone.
Haematologica 2007;92(10):1351-8.
2007: Terpos E; Dimopoulos M-A; Sezer O
The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(9):1875-84.
2007: Zervas K; Mihou D; Katodritou E; Pouli A; Mitsouli C H; Anagnostopoulos A; Delibasi S; Kyrtsonis M C; Anagnostopoulos N; Terpos E; Zikos P; Maniatis A; Dimopoulos M A;
VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek Myeloma Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(8):1369-75.
2007: Dimopoulos Meletios Athanasios; Anagnostopoulos Athanasios; Kyrtsonis Marie-Christine; Zervas Konstantinos; Tsatalas Constantinos; Kokkinis Garyfallia; Repoussis Panagiotis; Symeonidis Argyris; Delimpasi Souzana; Katodritou Eirini; Vervessou Elina; Michali Evridiki; Pouli Anastasia; Gika Dimitra; Vassou Amalia; Terpos Evangelos; Anagnostopoulos Nikolaos; Economopoulos Theophanis; Pangalis Gerasimos
Primary treatment of Waldenström macroglobulinemia with dexamethasone, rituximab, and cyclophosphamide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3344-9.
2007: Terpos Evangelos; Sezer Orhan; Croucher Peter; Dimopoulos Meletios-Athanassios
Myeloma bone disease and proteasome inhibition therapies.
Blood 2007;110(4):1098-104.
2007: Voskaridou Ersi; Tsetsos George; Tsoutsias Antonios; Spyropoulou Evgenia; Christoulas Dimitrios; Terpos Evangelos
Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations.
Haematologica 2007;92(6):738-43.
2007: Anagnostopoulos Athanasios; Eleftherakis-Papaiakovou Vangelis; Kastritis Efstathios; Tsionos Konstantinos; Bamias Aristotelis; Meletis John; Dimopoulos Meletios A; Terpos Evangelos
Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ration of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity.
British journal of haematology 2007;137(6):560-8.
2007: Katodritou Eirini; Terpos Evangelos; Zervas Konstantinos; Speletas Matthaios; Kapetanos Dimitrios; Kartsios Charalambos; Verrou Evgenia; Banti Anastasia; Effraimidou Smaragda; Christakis John
Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma.
Annals of hematology 2007;86(5):369-76.
2007: Terpos Evangelos; Verrou Evgenia; Banti Anastasia; Kaloutsi Vassiliki; Lazaridou Anna; Zervas Kostas
Bortezomib is an effective agent for MDS/MPD syndrome with 5q- anomaly and thrombocytosis.
Leukemia research 2007;31(4):559-62.
2007: Lipton Allan; Cook Richard J; Coleman Robert E; Smith Matthew R; Major Pierre; Terpos Evangelos; Berenson James R
Clinical utility of biochemical markers of bone metabolism for improving the management of patients with advanced multiple myeloma.
Clinical lymphoma & myeloma 2007;7(5):346-53.
2007: Galanopoulos Athanasios G; Symeonidis Argyris; Kourakli Aleka; Papadaki Eleni A; Tsaftaridis Panagiotis; Terpos Evangelos; Aktipi Anthi; Roussou Paraskevi; Protopappa Maria; Pappaioannou Maria; Zikos Panagiotis; Speletas Mattheos; Parcharidou Agapi; Laoutaris Nikolaos; Anagnostopoulos Nikolaos I; Meletis John; Pangalis Gerasimos A; Zoumbos Nikolaos; Viniou Nora;
Prognostic significance of deletion of the long arm of chromosome 20 in patients with myelodysplastic syndrome (MDS): a study of the Greek MDS Study Group.
European journal of haematology 2007;78(1):89-90.
2007: Mountzios Giannis; Dimopoulos Meletios-Athanassios; Bamias Aristotelis; Papadopoulos George; Kastritis Efstathios; Syrigos Konstantinos; Pavlakis George; Terpos Evangelos
Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton.
Acta oncologica (Stockholm, Sweden) 2007;46(2):221-9.
2007: Katodritou Eirini; Speletas Matthaios; Pouli Anastasia; Tsitouridis John; Zervas Konstantinos; Terpos Evangelos
Successful treatment of extramedullary plasmacytoma of the cavernous sinus using a combination of intermediate dose of thalidomide and dexamethasone.
Acta haematologica 2007;117(1):20-3.
2006: Terpos Evangelos
What's new in bone research--anabolics, tissue repair, therapeutic strategies and more.
IDrugs : the investigational drugs journal 2006;9(12):837-40.
2006: Terpos Evangelos; Heath Deborah J; Rahemtulla Amin; Zervas Kostas; Chantry Andrew; Anagnostopoulos Athanasios; Pouli Anastasia; Katodritou Eirini; Verrou Evgenia; Vervessou Elisavet-Christine; Dimopoulos Meletios-Athanassios; Croucher Peter I
Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma.
British journal of haematology 2006;135(5):688-92.
2006: Politou Marianna C; Heath Deborah J; Rahemtulla Amin; Szydlo Richard; Anagnostopoulos Athanasios; Dimopoulos Meletios A; Croucher Peter I; Terpos Evangelos
Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation.
International journal of cancer. Journal international du cancer 2006;119(7):1728-31.
2006: Voskaridou Ersi; Anagnostopoulos Athanasios; Konstantopoulos Kostas; Stoupa Eleni; Spyropoulou Evgenia; Kiamouris Christos; Terpos Evangelos
Zoledronic acid for the treatment of osteoporosis in patients with beta-thalassemia: results from a single-center, randomized, placebo-controlled trial.
Haematologica 2006;91(9):1193-202.
2006: Meletis John; Viniou Nora; Terpos Evangelos
Novel agents for the management of myelodysplastic syndromes.
Medical science monitor : international medical journal of experimental and clinical research 2006;12(9):RA194-206.
2006: Zervas Kostas; Verrou Evgenia; Teleioudis Zisis; Vahtsevanos Konstantinos; Banti Anastasia; Mihou Dimitra; Krikelis Dimitris; Terpos Evangelos
Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients.
British journal of haematology 2006;134(6):620-3.
2006: Dimopoulos Meletios Athanasios; Pouli Anastasia; Anagnostopoulos Athanasios; Repoussis Panagiotis; Symeonidis Argyris; Terpos Evangelos; Delimbasi Sosana; Tsolakis Friderikos; Economopoulos Theophanis; Zervas Constantinos
Macrofocal multiple myeloma in young patients: a distinct entity with favorable prognosis.
Leukemia & lymphoma 2006;47(8):1553-6.
2006: Kastritis Efstathios; Terpos Evangelos; Anagnostopoulos Athanasios; Xilouri Irini; Dimopoulos Meletios Athanasios
Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support.
Clinical lymphoma & myeloma 2006;7(1):73-6.
2006: Dimopoulos Meletios A; Kastritis Efstathios; Anagnostopoulos Athanasios; Melakopoulos Ioannis; Gika Dimitra; Moulopoulos Lia A; Bamia Christina; Terpos Evangelos; Tsionos Konstantinos; Bamias Aristotelis
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.
Haematologica 2006;91(7):968-71.
2006: Voskaridou Ersi; Stoupa Eleni; Antoniadou Lito; Premetis Evangelos; Konstantopoulos Kostas; Papassotiriou Ioannis; Terpos Evangelos
Osteoporosis and osteosclerosis in sickle cell/beta-thalassemia: the role of the RANKL/osteoprotegerin axis.
Haematologica 2006;91(6):813-6.
2006: Voskaridou E; Terpos E; Michail S; Hantzi E; Anagnostopoulos A; Margeli A; Simirloglou D; Loukopoulos D; Papassotiriou I
Early markers of renal dysfunction in patients with sickle cell/beta-thalassemia.
Kidney international 2006;69(11):2037-42.
2006: Terpos Evangelos; Eleutherakis-Papaiakovou Vangelis; Dimopoulos Meletios-Athanassios
Clinical implications of chromosomal abnormalities in multiple myeloma.
Leukemia & lymphoma 2006;47(5):803-14.
2006: Terpos Evangelos; Anagnostopoulos Athanasios; Kastritis Efstathios; Bamias Aristotelis; Tsionos Konstantinos; Dimopoulos Meletios-Athanassios
Abnormal bone remodelling and increased levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) in Waldenström macroglobulinaemia.
British journal of haematology 2006;133(3):301-4.
2006: O'Shea D; Giles C; Terpos E; Perz J; Politou M; Sana V; Naresh K; Lampert I; Samson D; Narat S; Kanfer E; Olavarria E; Apperley J F; Rahemtulla A
Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients.
Bone marrow transplantation 2006;37(8):731-7.
2006: Dimopoulos Meletios A; Anagnostopoulos Athanasios; Terpos Evangelos; Repoussis Panagiotis; Zomas Athanasios; Katodritou Eirini; Kyrtsonis Marie Christine; Delibasi Souzana; Vassou Amalia; Pouli Anastasia; Zervas Konstantinos; Anagnostopoulos Nikolaos; Maniatis Alice;
Primary treatment with pulsed melphalan, dexamethasone and thalidomide for elderly symptomatic patients with multiple myeloma.
Haematologica 2006;91(2):252-4.
2006: Politou Marianna; Karadimitris Anastasios; Terpos Evangelos; Kotsianidis Ioannis; Apperley Jane F; Rahemtulla Amin
No evidence of mutations of the PSMB5 (beta-5 subunit of proteasome) in a case of myeloma with clinical resistance to Bortezomib.
Leukemia research 2006;30(2):240-1.
2006: Pavlakis G; Mountzios G; Terpos E; Leivaditou A; Papadopoulos G; Papasavas P
Recurrent ovarian cancer metastatic to the sternum, costae, and thoracic wall after prolonged treatment with platinum-based chemotherapy: a case report and review of the literature.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 1():299-303.
2006: Rahemtulla Amin; Terpos Evangelos
Hodgkin's lymphoma.
Clinical evidence 2006;2006():.
2006: Mountzios Giannis; Pavlakis George; Terpos Evangelos; Sakorafas George; Revelos Kyriakos; Bamias Aristotelis; Nikolaou Nikolaos; Papasavas Pantelis; Soria Jean-Charles; Dimopoulos Meletios-Athanasios
Concurrent development of testicular seminoma and choriocarcinoma of the superior mediastinum, presented as cervical mass: a case report and implications about pathogenesis of germ-cell tumours.
BMC clinical pathology 2006;6():8.
2006: Terpos Evangelos
Biochemical markers of bone metabolism in multiple myeloma.
Cancer treatment reviews 2006;32 Suppl 1():15-9.
2005: Bamias Aristotle; Kastritis Efstathios; Bamia Christina; Moulopoulos Lia A; Melakopoulos Ioannis; Bozas George; Koutsoukou Vassiliki; Gika Dimitra; Anagnostopoulos Athanasios; Papadimitriou Christos; Terpos Evagelos; Dimopoulos Meletios A
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8580-7.
2005: Terpos Evangelos; Politou Marianna; Viniou Nora; Rahemtulla Amin
Significance of macrophage inflammatory protein-1 alpha (MIP-1alpha) in multiple myeloma.
Leukemia & lymphoma 2005;46(12):1699-707.
2005: Terpos Evangelos; Rezvani Katayoun; Basu Supratik; Milne Alison E; Rose Peter E; Scott Geoffrey L; Rahemtulla Amin; Samson Diana; Apperley Jane F
Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma.
European journal of haematology 2005;75(5):376-83.
2005: Terpos E; Mihou D; Szydlo R; Tsimirika K; Karkantaris C; Politou M; Voskaridou E; Rahemtulla A; Dimopoulos M A; Zervas K
The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL/osteoprotegerin ratio.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(11):1969-76.
2005: Jones Amy V; Kreil Sebastian; Zoi Katerina; Waghorn Katherine; Curtis Claire; Zhang Lingyan; Score Joannah; Seear Rachel; Chase Andrew J; Grand Francis H; White Helen; Zoi Christine; Loukopoulos Dimitris; Terpos Evangelos; Vervessou Elisavet-Christine; Schultheis Beate; Emig Michael; Ernst Thomas; Lengfelder Eva; Hehlmann Rüdiger; Hochhaus Andreas; Oscier David; Silver Richard T; Reiter Andreas; Cross Nicholas C P
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders.
Blood 2005;106(6):2162-8.
2005: Terpos E; Dimopoulos M-A
Myeloma bone disease: pathophysiology and management.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(8):1223-31.
2005: Mavrogianni Despina; Tsaftaridis Panagiotis; Terpos Evangelos; Symeonidis Argiris; Galanopoulus Athanasios; Papadaki Eleni A; Zoumbos Nicholas; Meletis John; Pangalis Gerassimos A; Viniou Nora
Macrophage Inflammatory Protein-1 alpha (MIP-1alpha) is over-expressed in a cohort of patients with myelodysplastic syndromes.
European journal of haematology 2005;75(1):85-6.
2005: Voskaridou Ersi; Douskou Maroussa; Terpos Evangelos; Stamoulakatou Alexandra; Meletis John; Ourailidis Akis; Papassotiriou Ioannis; Loukopoulos Dimitris
Deferiprone as an oral iron chelator in sickle cell disease.
Annals of hematology 2005;84(7):434-40.
2005: Terpos Evangelos; Rahemtulla Amin; Dimopoulos Meletios-Athanassios
Current treatment options for myeloma.
Expert opinion on pharmacotherapy 2005;6(7):1127-42.
2005: Terpos Evangelos; Politou Marianna; Rahemtulla Amin
The role of markers of bone remodeling in multiple myeloma.
Blood reviews 2005;19(3):125-42.
2005: Voskaridou Ersi; Terpos Evangelos
Osteoprotegerin to soluble receptor activator of nuclear factor kappa-B ligand ratio is reduced in patients with thalassaemia-related osteoporosis who receive vitamin D3.
European journal of haematology 2005;74(4):359-61.
2005: Anagnostopoulos George K; Sakorafas George H; Kostopoulos Panagiotis; Margantinis George; Tsiakos Stavros; Terpos Evaggelos; Pavlakis George; Fortun Paul; Arvanitidis Dimitrios
Disseminated colon cancer with severe peripheral blood eosinophilia and elevated serum levels of interleukine-2, interleukine-3, interleukine-5, and GM-CSF.
Journal of surgical oncology 2005;89(4):273-5.
2005: Politou Marianna; Naresh Kikkeri; Terpos Evangelos; Crawley Danielle; Lampert Irvin; Apperley Jane F; Rahemtulla Amin
Anti-angiogenic effect of bortezomib in patients with multiple myeloma.
Acta haematologica 2005;114(3):170-3.
2004: Hatjiharissi E; Terpos E; Papaioannou M; Hatjileontis C; Kaloutsi V; Galaktidou G; Gerotziafas G; Christakis J; Zervas K
The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
Hematological oncology 2004;22(4):159-68.
2004: Terpos Evangelos; Theocharis Stamatios; Panitsas Fotios; Philippidis Theodoros; Kotronis Epaminondas; Karkantaris Christos
Autoimmune hemolytic anemia with myelodysplastic features followed by bilateral adrenal non-hodgkin lymphoma: a case report and review of the literature.
Leukemia & lymphoma 2004;45(11):2333-8.
2004: Voskaridou Ersi; Terpos Evangelos
New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia.
British journal of haematology 2004;127(2):127-39.
2004: Terpos Evangelos; Politou Marianna; Rahemtulla Amin
Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration.
Journal of cancer research and clinical oncology 2004;130(10):623-5.
2004: Voskaridou Ersi; Douskou Maroussa; Terpos Evangelos; Papassotiriou Ioannis; Stamoulakatou Alexandra; Ourailidis Akis; Loutradi Aphroditi; Loukopoulos Dimitris
Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
British journal of haematology 2004;126(5):736-42.
2004: Politou Marianna; Terpos Evangelos; Anagnostopoulos Athanasios; Szydlo Richard; Laffan Michael; Layton Mark; Apperley Jane F; Dimopoulos Meletios-Athanasios; Rahemtulla Amin
Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS).
British journal of haematology 2004;126(5):686-9.
2004: Terpos E; Politou M; Szydlo R; Nadal E; Avery S; Olavarria E; Kanfer E; Goldman J M; Apperley J F; Rahemtulla A
Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL/osteoprotegerin ratio in patients with multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(8):1420-6.
2004: Terpos Evangelos; Rahemtulla Amin
Bisphosphonate treatment for multiple myeloma.
Drugs of today (Barcelona, Spain : 1998) 2004;40(1):29-40.
2003: Terpos Evangelos; Politou Marianna; Rahemtulla Amin
New insights into the pathophysiology and management of bone disease in multiple myeloma.
British journal of haematology 2003;123(5):758-69.
2003: Terpos Evangelos; Samarkos Michalis; Meletis Christos; Apostolidou Effie; Tsironi Maria; Korovesis Konstantinos; Mavrogianni Despina; Viniou Nora; Meletis John
Unusual association between increased bone resorption and presence of paroxysmal nocturnal hemoglobinuria phenotype in multiple myeloma.
International journal of hematology 2003;78(4):344-8.
2003: Voskaridou Ersi; Terpos Evangelos; Spina Giovanna; Palermos John; Rahemtulla Amin; Loutradi Aphroditi; Loukopoulos Dimitris
Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia.
British journal of haematology 2003;123(4):730-7.
2003: Terpos Evangelos; Politou Marianna; Szydlo Richard; Goldman John M; Apperley Jane F; Rahemtulla Amin
Serum levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) correlate with the extent of bone disease and survival in patients with multiple myeloma.
British journal of haematology 2003;123(1):106-9.
2003: Terpos Evangelos; de la Fuente Josu; Szydlo Richard; Hatjiharissi Evdoxia; Viniou Nora; Meletis John; Yataganas Xenophon; Goldman John M; Rahemtulla Amin
Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
International journal of cancer. Journal international du cancer 2003;106(3):455-7.
2003: Terpos Evangelos; Szydlo Richard; Apperley Jane F; Hatjiharissi Evdoxia; Politou Marianna; Meletis John; Viniou Nora; Yataganas Xenophon; Goldman John M; Rahemtulla Amin
Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index.
Blood 2003;102(3):1064-9.
2003: Meletis John; Terpos Evangelos
Recent insights into the pathophysiology of paroxysmal nocturnal hemoglobinuria.
Medical science monitor : international medical journal of experimental and clinical research 2003;9(7):RA161-72.
2003: Dimopoulos M A; Pouli A; Zervas K; Grigoraki V; Symeonidis A; Repoussis P; Mitsouli C; Papanastasiou C; Margaritis D; Tokmaktsis A; Katodritou I; Kokkini G; Terpos E; Vyniou N; Tzilianos M; Chatzivassili A; Kyrtsonis M C; Panayiotidis P; Maniatis A;
Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(7):1039-44.
2003: Kalotychou Vassiliki; Antonatou Katerina; Tzanetea Revekka; Terpos Evaggelos; Loukopoulos Dimitris; Rombos Yannis
Analysis of the A(TA)(n)TAA configuration in the promoter region of the UGT1 A1 gene in Greek patients with thalassemia intermedia and sickle cell disease.
Blood cells, molecules & diseases 2003;31(1):38-42.
2003: Akel Salem; Mavroyanni Despina; Yataganas Xenophon; Terpos Evagelos; Meletis John; Anargyrou Kostas; Stavrogianni Niki; Pangalis Gerasimos-Alexander; Loukopoulos Dimitris; Viniou Nora
Clonal analysis of granulocyte-monocyte colony-forming unit cells with the human androgen receptor gene in chronic myeloid leukemia.
International journal of hematology 2003;77(5):476-81.
2003: Terpos E; Apperley J F; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman J M; Rahemtulla A
Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
Bone marrow transplantation 2003;31(3):163-70.
2003: Terpos Evangelos; Viniou Nora; de la Fuente Josu; Meletis John; Voskaridou Ersi; Karkantaris Christos; Vaiopoulos George; Palermos John; Yataganas Xenophon; Goldman John M; Rahemtulla Amin
Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and beta 2-microglobulin in multiple myeloma.
European journal of haematology 2003;70(1):34-42.
2003: Korkolopoulou P; Viniou N; Kavantzas N; Patsouris E; Thymara I; Pavlopoulos P M; Terpos E; Stamatopoulos K; Plata E; Anargyrou K; Androulaki A; Davaris P; Yataganas X
Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(1):89-97.
2002: Terpos Evangelos; Mougiou Athina; Kouraklis Alexandra; Chatzivassili Aria; Michalis Evridiki; Giannakoulas Nicholas; Manioudaki Eleni; Lazaridou Anna; Bakaloudi Vassiliki; Protopappa Maria; Liapi Dimitra; Grouzi Elisavet; Parharidou Agapi; Symeonidis Argyris; Kokkini Garoufalia; Laoutaris Nikolaos P; Vaipoulos George; Anagnostopoulos Nikolaos I; Christakis John I; Meletis John; Bourantas Konstantinos L; Zoumbos Nicholas C; Yataganas Xenophon; Viniou Nora-Athina;
Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients.
British journal of haematology 2002;118(1):174-80.
2002: Mavrogianni Despina; Viniou Nora; Michali Evi; Terpos Evangelos; Meletis John; Vaiopoulos George; Madzourani Marina; Pangalis Gerasimos; Yataganas Xenophon; Loukopoulos Dimitris
Leukemogenic risk of hydroxyurea therapy as a single agent in polycythemia vera and essential thrombocythemia: N- and K-ras mutations and microsatellite instability in chromosomes 5 and 7 in 69 patients.
International journal of hematology 2002;75(4):394-400.
2002: Meletis John; Terpos Evangelos; Samarkos Michalis; Meletis Christos; Apostolidou Effie; Komninaka Veroniki; Anargyrou Konstantinos; Korovesis Konstantinos; Mavrogianni Despina; Variami Eleni; Viniou Nora; Konstantopoulos Konstantinos
Red cells with paroxysmal nocturnal hemoglobinuria-phenotype in patients with acute leukemia.
Hematology (Amsterdam, Netherlands) 2002;7(2):69-74.
2002: Viniou N; Terpos E; Galanopoulos A; Kritikou-Griva E; Akel S; Michalis E; Apostolidou E; Georgiadou D; Kouraklis A; Parharidou A; Kokkini G; Symeonidis A; Anagnostopoulos N I; Christakis J I; Tasiopoulou A; Loukopoulos D; Yataganas X
Treatment of anemia in low-risk myelodysplastic syndromes with amifostine. In vitro testing of response.
Annals of hematology 2002;81(4):182-6.
2002: Meletis John; Terpos Evangelos; Samarkos Michalis; Meletis Christos; Apostolidou Effie; Komninaka Veroniki; Korovesis Konstantinos; Anargyrou Konstantinos; Benopoulou Olga; Mavrogianni Despina; Variami Eleni; Viniou Nora; Konstantopoulos Konstantinos
Detection of CD55- and/or CD59-deficient red cell populations in patients with plasma cell dyscrasias.
International journal of hematology 2002;75(1):40-4.
2002: Voskaridou Ersi; Terpos Evangelos; Komninaka Veroniki; Eftyhiadis Eftyhios; Mantzourani Marina; Loukopoulos Dimitris
Chronic myeloid leukaemia with marked thrombocytosis in a patient with thalassaemia major: complete haematological remission under the combination of hydroxyurea and anagrelide.
British journal of haematology 2002;116(1):155-7.
2002: Anargyrou Konstantinos; Vaiopoulos George; Terpos Evangelos; Tsironi Maria; Konstantopoulos Konstantinos; Samarkos Michael; Meletis John
Low dose melphalan is a treatment option in elderly patients with high risk myelodysplastic syndrome or secondary acute myeloblastic leukaemia.
Haematologia 2002;32(2):169-73.
2002: Viniou Nora; Plata Eleni; Terpos Evangelos; Variami Eleni; Meletis John; Vaiopoulos George; Loukopoulos Dimitris; Chatzidimitriou Georgia; Yataganas Xenophon
Danazol therapy for thrombocytopenia in patients with myelodysplastic syndromes.
Acta haematologica 2002;107(4):234-6.
2001: Viniou N; Terpos E; Rombos J; Vaiopoulos G; Nodaros K; Stamatopoulos K; Meletis J; Yataganas X
Acute myeloid leukemia in a patient with ataxia-telangiectasia: a case report and review of the literature.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(10):1668-70.
2001: Korkolopoulou P; Apostolidou E; Pavlopoulos P M; Kavantzas N; Vyniou N; Thymara I; Terpos E; Patsouris E; Yataganas X; Davaris P
Prognostic evaluation of the microvascular network in myelodysplastic syndromes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(9):1369-76.
2001: Terpos E; Palermos J; Viniou N; Vaiopoulos G; Meletis J; Yataganas X
Pamidronate increases markers of bone formation in patients with multiple myeloma in plateau phase under interferon-alpha treatment.
Calcified tissue international 2001;68(5):285-90.
2001: Vaiopoulos G; Terpos E; Viniou N; Nodaros K; Rombos J; Loukopoulos D
Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.
American journal of hematology 2001;66(1):57-8.
2001: Voskaridou E; Kyrtsonis M C; Terpos E; Skordili M; Theodoropoulos I; Bergele A; Diamanti E; Kalovidouris A; Loutradi A; Loukopoulos D
Bone resorption is increased in young adults with thalassaemia major.
British journal of haematology 2001;112(1):36-41.
2001: Meletis J; Terpos E; Samarkos M; Meletis C; Apostolidou E; Komninaka V; Korovesis K; Mavrogianni D; Boutsis D; Variami E; Viniou N; Konstantopoulos K; Loukopoulos D
Detection of CD55- and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(1):33-7.
2001: Meletis J; Terpos E; Samarkos M; Meletis C; Konstantopoulos K; Komninaka V; Apostolidou E; Benopoulou O; Korovesis K; Mavrogianni D; Variami E; Yataganas X; Loukopoulos D
Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disorders.
Haematologia 2001;31(1):7-16.
2000: Terpos E; Palermos J; Tsionos K; Anargyrou K; Viniou N; Papassavas P; Meletis J; Yataganas X
Effect of pamidronate administration on markers of bone turnover and disease activity in multiple myeloma.
European journal of haematology 2000;65(5):331-6.
2000: Terpos E; Angelopoulou M K; Variami E; Meletis J C; Vaiopoulos G
Sjögren's syndrome associated with multiple myeloma.
Annals of hematology 2000;79(8):449-51.
2000: Papanikolaou G; Politou M; Terpos E; Fourlemadis S; Sakellaropoulos N; Loukopoulos D
Hereditary hemochromatosis: HFE mutation analysis in Greeks reveals genetic heterogeneity.
Blood cells, molecules & diseases 2000;26(2):163-8.
1999: Variami E; Terpos E; Vgenopoulou S; Kanellopoulou G; Meletis J
Inflammatory pseudotumor of the spleen: a case report and review of the literature.
Annals of hematology 1999;78(12):560-3.
1998: Konstantopoulos K; Terpos E; Prinolakis H; Kanta A; Variami E; Kanellopoulou G; Vaiopoulos G; Floros A; Androulaki A; Meletis J
Systemic lupus erythematosus presenting as myelofibrosis.
Haematologia 1998;29(2):153-6.
1998: Meletis J; Samarkos M; Mesogitis S; Meletis C; Mougiou A; Terpos E; Tsimberidou A; Andreopoulos A; Konstantopoulos K; Loukopoulos D
Severe aplastic anaemia relapsing during a pregnancy; spontaneous remission following termination.
Haematologia 1998;29(2):147-51.
1997: Meletis J; Michali E; Samarkos M; Konstantopoulos K; Meletis C; Terpos E; Tsimberidou A; Chandrinou E; Viniou N; Rombos Y; Pangalis G A; Yataganas X; Loukopoulos D
Detection of "PNH red cell" populations in hematological disorders using the Sephacryl Gel Test micro typing system.
Leukemia & lymphoma 1997;28(1-2):177-82.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Evangelos Terpos

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Physiology

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Evangelos Terpos (preview)

All Publications